Acquisition of Roche reagents and consumables
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Roche Diagnostics Corporation for the Roche reagents and consumables that are compatible with the Roche MagNA Pure 96 instrument and the CDC Trioplex RT-PCR Assay. These are approved for the molecular diagnosis of Zika virus and approved by the FDA under an Emergency Use Aurhorization. No other brand or materials/reagents are validated for this use and are not compatible with the current systems. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.
This notice of intent is not a request for competitive quotations; however, all quotations/responses received within five (5) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at yrj7@cdc.gov by 12:00 p.m., Saturday, December 16th, 2017.
Laurie Michelle Taylor, Phone 7707294480, Email yrj7@cdc.gov
